ENFUSION INC - CLASS A (ENFN)
US2928121043 - Common Stock
Notable Two Hundred Day Moving Average Cross - ENFN
Enfusion Announces Date of First Quarter 2024 Results
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Enfusion, Inc. - ENFN
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Enfusion, Inc. ("Enfusion" or the "Company") (NYSE: ENFN). Such investors are...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Enfusion, Inc. - ENFN
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Enfusion, Inc. ("Enfusion" or the "Company") (NYSE: ENFN). Such investors are...
The 3 Most Undervalued Under-$10 Stocks to Buy in April 2024
Equities have only become more expensive, but investors should still lookout for the most undervalued under-$10 stocks to buy in April.
The 3 Most Undervalued Under-$10 Stocks to Buy in April 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Discovering and allocating to undervalued stocks is a key element of ...
Bullish Two Hundred Day Moving Average Cross - ENFN
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Enfusion, Inc. - ENFN
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Enfusion, Inc. ("Enfusion" or the "Company") (NYSE: ENFN). Such investors are...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Enfusion, Inc. - ENFN
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Enfusion, Inc. ("Enfusion" or the "Company") (NYSE: ENFN). Such investors are...
Wall Street Favorites: 3 Under-$10 Stocks with Strong Buy Ratings for March 2024
U.S. equities market is rallying, but there are still interesting investments to make, especially for these strong-buy stocks under $10.
ENFN Makes Bullish Cross Above Critical Moving Average
Enfusion Announces Fourth Quarter 2023 Results and Full Year 2023 Results
Notable Monday Option Activity: ENFN, LVS, GE
Commit To Buy Enfusion At $7.50, Earn 182.5% Annualized Using Options
Enfusion Stock To Remain Range-Bound In 2024 Amid Stable Hedge Fund Market: Goldman Sachs Analyst Downgrades Stock
Goldman Sachs downgrades Enfusion from Neutral to Sell, lowers price target from $9 to $8, expects stock to be range-bound in 2024 with slower growth than Street estimates due to company-specific challenges. Analyst will watch for improvements to become more positive on the stock.
Enfusion stock retreats after Goldman downgrades to Sell (NYSE:ENFN)
Goldman Sachs downgraded Enfusion stock, causing a 7.1% slide.
Enfusion Breaks Above 200-Day Moving Average - Bullish for ENFN
Enfusion Announces Date of Fourth Quarter and Full Year 2023 Results
Enfusion to Host Investor Day on March 19, 2024
Kore.ai Secures $150 Million Strategic Growth Investment to Drive AI-powered Customer and Employee Experiences for Global Brands
/PRNewswire/ -- Kore.ai, a leader in enterprise conversational and generative AI platform technology, today announced $150 million in funding. The strategic...
BillingPlatform Secures $90 Million Growth Equity Investment from FTV Capital
/PRNewswire/ -- BillingPlatform, the enterprise revenue lifecycle management platform for today's innovative business models, today announced a $90 million...
Enfusion is Now Oversold (ENFN)
Hidden Gems: 3 Small-Cap Tech Stocks With Huge Potential
These top small-cap tech stocks are the ones to buy in for long-term returns as profits are evident from innovations.
Commit To Purchase Enfusion At $7.50, Earn 8.8% Annualized Using Options
Enfusion reports appointment of chief operating officer (NYSE:ENFN)
Enfusion, a financial technology company, has appointed Neal Pawar as Chief Operating Officer.
Enfusion Announces Appointment of Chief Operating Officer
Notable Thursday Option Activity: ENFN, ANET, AMZN
Enfusion Announces Third Quarter 2023 Results
Enfusion Announces Date of Third Quarter 2023 Results
Enfusion Launches Portfolio Workbench, Empowering Portfolio Managers to Seamlessly Rebalance Multi-Asset Portfolios
The 3 Most Undervalued Under-$10 Stocks to Buy in September 2023
Undervalued stocks are not just found in older industries; rather, many can be found in emerging spaces as well.